Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Four-meter gait speed predicts daily physical activity in patients with chronic respiratory diseases.

Yoshida C, Ichiyasu H, Ideguchi H, Hirosako S, Masunaga A, Kojima K, Saeki S, Fujii K, Sakagami T, Kohrogi H.

Respir Investig. 2019 Jul;57(4):368-375. doi: 10.1016/j.resinv.2019.03.009. Epub 2019 May 13.

PMID:
31092319
2.

Induction of migration of periodontal ligament cells by selective regulation of integrin subunits.

Kawamura M, Yamamoto T, Yamashiro K, Kochi S, Yoshihara-Hirata C, Ideguchi H, Aoyagi H, Omori K, Takashiba S.

J Cell Mol Med. 2019 Feb;23(2):1211-1223. doi: 10.1111/jcmm.14023. Epub 2018 Dec 3.

3.

Molecular imaging assessment of periodontitis lesions in an experimental mouse model.

Ideguchi H, Yamashiro K, Yamamoto T, Shimoe M, Hongo S, Kochi S, Yoshihara-Hirata C, Aoyagi H, Kawamura M, Takashiba S.

Clin Oral Investig. 2019 Feb;23(2):821-827. doi: 10.1007/s00784-018-2510-2. Epub 2018 Jun 6.

PMID:
29876665
4.

Anti-HMGB1 Neutralizing Antibody Attenuates Periodontal Inflammation and Bone Resorption in a Murine Periodontitis Model.

Yoshihara-Hirata C, Yamashiro K, Yamamoto T, Aoyagi H, Ideguchi H, Kawamura M, Suzuki R, Ono M, Wake H, Nishibori M, Takashiba S.

Infect Immun. 2018 Apr 23;86(5). pii: e00111-18. doi: 10.1128/IAI.00111-18. Print 2018 May.

5.

HMGB1-induced inflammatory response promotes bone healing in murine tooth extraction socket.

Aoyagi H, Yamashiro K, Hirata-Yoshihara C, Ideguchi H, Yamasaki M, Kawamura M, Yamamoto T, Kochi S, Wake H, Nishibori M, Takashiba S.

J Cell Biochem. 2018 Jul;119(7):5481-5490. doi: 10.1002/jcb.26710. Epub 2018 Mar 14.

PMID:
29377249
6.

Modulation of microenvironment for controlling the fate of periodontal ligament cells: the role of Rho/ROCK signaling and cytoskeletal dynamics.

Yamamoto T, Ugawa Y, Kawamura M, Yamashiro K, Kochi S, Ideguchi H, Takashiba S.

J Cell Commun Signal. 2018 Mar;12(1):369-378. doi: 10.1007/s12079-017-0425-3. Epub 2017 Oct 30. Review.

7.

Clinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonias.

Okabayashi H, Ichiyasu H, Hirooka S, Akaike K, Kojima K, Jodai T, Sakamoto Y, Ideguchi H, Hamada S, Yoshida C, Hirosako S, Okamoto S, Kohrogi H.

BMC Pulm Med. 2017 Oct 24;17(1):134. doi: 10.1186/s12890-017-0479-2.

8.

Aggregatibacter actinomycetemcomitans regulates the expression of integrins and reduces cell adhesion via integrin α5 in human gingival epithelial cells.

Kochi S, Yamashiro K, Hongo S, Yamamoto T, Ugawa Y, Shimoe M, Kawamura M, Hirata-Yoshihara C, Ideguchi H, Maeda H, Takashiba S.

Mol Cell Biochem. 2017 Dec;436(1-2):39-48. doi: 10.1007/s11010-017-3076-z. Epub 2017 Jun 7.

PMID:
28593565
9.

Efficacy of direct hemoperfusion using polymyxin B-immobilized fiber column (PMX-DHP) in rapidly progressive interstitial pneumonias: results of a historical control study and a review of previous studies.

Ichiyasu H, Horio Y, Masunaga A, Migiyama Y, Sakamoto Y, Jodai T, Ideguchi H, Okabayashi H, Hamada S, Yoshida C, Hirosako S, Okamoto S, Kohrogi H.

Ther Adv Respir Dis. 2017 Jul;11(7):261-275. doi: 10.1177/1753465817708950. Epub 2017 May 30. Review.

10.

The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trial.

Izumi Y, Akazawa M, Akeda Y, Tohma S, Hirano F, Ideguchi H, Matsumura R, Miyamura T, Mori S, Fukui T, Iwanaga N, Jiuchi Y, Kozuru H, Tsutani H, Saisyo K, Sugiyama T, Suenaga Y, Okada Y, Katayama M, Ichikawa K, Furukawa H, Kawakami K, Oishi K, Migita K.

Arthritis Res Ther. 2017 Jan 25;19(1):15. doi: 10.1186/s13075-016-1207-7.

11.

Continuous evolution of clinical phenotype in 578 Japanese patients with Behçet's disease: a retrospective observational study.

Kirino Y, Ideguchi H, Takeno M, Suda A, Higashitani K, Kunishita Y, Takase-Minegishi K, Tamura M, Watanabe T, Asami Y, Uehara T, Yoshimi R, Yamazaki T, Sekiguchi A, Ihata A, Ohno S, Ueda A, Igarashi T, Nagaoka S, Ishigatsubo Y, Nakajima H.

Arthritis Res Ther. 2016 Oct 3;18(1):217.

12.

Smad2 overexpression enhances adhesion of gingival epithelial cells.

Hongo S, Yamamoto T, Yamashiro K, Shimoe M, Tomikawa K, Ugawa Y, Kochi S, Ideguchi H, Maeda H, Takashiba S.

Arch Oral Biol. 2016 Nov;71:46-53. doi: 10.1016/j.archoralbio.2016.06.025. Epub 2016 Jun 29.

PMID:
27421099
13.

Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate.

Migita K, Akeda Y, Akazawa M, Tohma S, Hirano F, Ideguchi H, Matsumura R, Suematsu E, Miyamura T, Mori S, Fukui T, Izumi Y, Iwanaga N, Jiuchi Y, Kozuru H, Tsutani H, Saisyo K, Yamanaka T, Ohshima S, Mori N, Matsumori A, Kitagawa K, Takahi K, Ozawa T, Hamada N, Nakajima K, Nagai H, Tamura N, Suenaga Y, Kawabata M, Matsui T, Furukawa H, Kawakami K, Oishi K.

Medicine (Baltimore). 2015 Dec;94(52):e2184. doi: 10.1097/MD.0000000000002184. Erratum in: Medicine (Baltimore). 2016 Feb;95(8):e8362. Oish, Kazunori [Corrected to Oishi, Kazunori].

14.

Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients.

Migita K, Akeda Y, Akazawa M, Tohma S, Hirano F, Ideguchi H, Kozuru H, Jiuchi Y, Matsumura R, Suematsu E, Miyamura T, Mori S, Fukui T, Izumi Y, Iwanaga N, Tsutani H, Saisyo K, Yamanaka T, Ohshima S, Mori N, Matsumori A, Takahi K, Yoshizawa S, Kawabe Y, Suenaga Y, Ozawa T, Hamada N, Komiya Y, Matsui T, Furukawa H, Oishi K.

Arthritis Res Ther. 2015 Dec 10;17:357. doi: 10.1186/s13075-015-0863-3.

15.

Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus.

Migita K, Akeda Y, Akazawa M, Tohma S, Hirano F, Ideguchi H, Matsumura R, Suematsu E, Miyamura T, Mori S, Fukui T, Izumi Y, Iwanaga N, Tsutani H, Saisyo K, Yamanaka T, Ohshima S, Sugiyama T, Kawabe Y, Katayama M, Suenaga Y, Okamoto A, Ohshima H, Okada Y, Ichikawa K, Yoshizawa S, Kawakami K, Matsui T, Furukawa H, Oishi K.

Arthritis Res Ther. 2015 Jun 3;17:149. doi: 10.1186/s13075-015-0662-x.

16.

Cisplatin-induced eosinophilic pneumonia.

Ideguchi H, Kojima K, Hirosako S, Ichiyasu H, Fujii K, Kohrogi H.

Case Rep Pulmonol. 2014;2014:209732. doi: 10.1155/2014/209732. Epub 2014 Nov 13.

17.

Osteogenic differentiation regulated by Rho-kinase in periodontal ligament cells.

Yamamoto T, Ugawa Y, Yamashiro K, Shimoe M, Tomikawa K, Hongo S, Kochi S, Ideguchi H, Maeda H, Takashiba S.

Differentiation. 2014 Sep-Oct;88(2-3):33-41. doi: 10.1016/j.diff.2014.09.002. Epub 2014 Sep 29.

PMID:
25278479
18.

Development of pulmonary and cardiac sarcoidosis during etanercept therapy.

Miyagi R, Ideguchi H, Soga T, Yamakawa Y, Otsuki H, Niino H, Shiina T, Ueda A, Ishigatsubo Y.

Int J Rheum Dis. 2014 Sep;17(7):810-2. doi: 10.1111/1756-185X.12178. Epub 2013 Oct 31. No abstract available.

PMID:
24460777
19.

Interstitial pneumonia as an initial manifestation in a patient with late-onset SLE.

Miyagi R, Ideguchi H, Soga T, Sakamoto K, Niino H, Shiina T, Ueda A, Ishigatsubo Y.

Int J Rheum Dis. 2014 Sep;17(7):813-6. doi: 10.1111/1756-185X.12282. Epub 2014 Jan 23. No abstract available.

PMID:
24450298
20.

Early onset and focal spike discharges as indicators of poor prognosis for myoclonic-astatic epilepsy.

Inoue T, Ihara Y, Tomonoh Y, Nakamura N, Ninomiya S, Fujita T, Ideguchi H, Yasumoto S, Zhang B, Hirose S.

Brain Dev. 2014 Aug;36(7):613-9. doi: 10.1016/j.braindev.2013.08.009. Epub 2013 Sep 19.

PMID:
24055341
21.

Gastrointestinal manifestations of Behçet's disease in Japan: a study of 43 patients.

Ideguchi H, Suda A, Takeno M, Miyagi R, Ueda A, Ohno S, Ishigatsubo Y.

Rheumatol Int. 2014 Jun;34(6):851-6. doi: 10.1007/s00296-013-2838-5. Epub 2013 Aug 10.

PMID:
23934478
22.

A Pancreatic Solid Pseudo-Papillary Tumor Detected After Abdominal Injury.

Ishii A, Yoshimura K, Ideguchi H, Hirose S.

Gastroenterology Res. 2013 Apr;6(2):67-70. Epub 2013 May 3.

23.

Reduced PLP1 expression in induced pluripotent stem cells derived from a Pelizaeus-Merzbacher disease patient with a partial PLP1 duplication.

Shimojima K, Inoue T, Imai Y, Arai Y, Komoike Y, Sugawara M, Fujita T, Ideguchi H, Yasumoto S, Kanno H, Hirose S, Yamamoto T.

J Hum Genet. 2012 Sep;57(9):580-6. doi: 10.1038/jhg.2012.71. Epub 2012 Jun 14.

PMID:
22695888
24.

Simultaneous evaluation of long-lasting knee synovitis in patients undergoing arthroplasty by power Doppler ultrasonography and contrast-enhanced MRI in comparison with histopathology.

Takase K, Ohno S, Takeno M, Hama M, Kirino Y, Ihata A, Ideguchi H, Mochida Y, Tateishi U, Shizukuishi K, Nagashima Y, Aoki I, Ishigatsubo Y.

Clin Exp Rheumatol. 2012 Jan-Feb;30(1):85-92. Epub 2012 Mar 7.

PMID:
22325923
25.

Characteristics of vascular involvement in Behçet's disease in Japan: a retrospective cohort study.

Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y.

Clin Exp Rheumatol. 2011 Jul-Aug;29(4 Suppl 67):S47-53. Epub 2011 Sep 27.

PMID:
21968236
26.

Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with rheumatoid arthritis treated with methotrexate.

Watanabe K, Takase K, Ohno S, Ideguchi H, Nozaki A, Ishigatsubo Y.

Mod Rheumatol. 2012 Jun;22(3):470-3. doi: 10.1007/s10165-011-0521-9. Epub 2011 Sep 8.

PMID:
21901356
27.

Expression patterns of the tumor suppressor PDCD4 and correlation with β-catenin expression in gastric cancers.

Kakimoto T, Shiraishi R, Iwakiri R, Fujimoto K, Takahashi H, Hamajima H, Mizuta T, Ideguchi H, Toda S, Kitajima Y, Ozaki I, Matsuhashi S.

Oncol Rep. 2011 Dec;26(6):1385-92. doi: 10.3892/or.2011.1450. Epub 2011 Sep 5.

PMID:
21894439
28.

Diagnosing nocturnal frontal lobe epilepsy: a case study of two children.

Tomonoh Y, Yasumoto S, Ihara Y, Fujita T, Nakamura N, Ninomiya S, Kodama R, Ideguchi H, Inoue T, Mitsudome A, Hirose S.

Seizure. 2011 Sep;20(7):583-5. doi: 10.1016/j.seizure.2011.03.004. Epub 2011 Apr 21.

29.

Pregnancy outcomes in Japanese patients with SLE: retrospective review of 55 pregnancies at a university hospital.

Ideguchi H, Ohno S, Uehara T, Ishigatsubo Y.

Clin Rev Allergy Immunol. 2013 Feb;44(1):57-64. doi: 10.1007/s12016-011-8269-8. Review.

PMID:
21394426
30.

Behçet disease: evolution of clinical manifestations.

Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y.

Medicine (Baltimore). 2011 Mar;90(2):125-32. doi: 10.1097/MD.0b013e318211bf28.

31.

Completion rate and compliance of anti-tuberculosis chemoprophylaxis in patients with rheumatic disease receiving tumor necrosis factor antagonists.

Ideguchi H, Ohno S, Takase K, Kirino Y, Suda A, Ihata A, Ueda A, Takeno M, Nagaoka S, Ishigatsubo Y.

Clin Exp Rheumatol. 2010 Mar-Apr;28(2):294-5. Epub 2010 May 14. No abstract available.

PMID:
20483059
32.

Use of musculoskeletal ultrasound in Japan: a survey of practicing rheumatologists.

Takase K, Ohno S, Ideguchi H, Takeno M, Shirai A, Ishigatsubo Y.

Mod Rheumatol. 2010 Aug;20(4):376-80. doi: 10.1007/s10165-010-0293-7. Epub 2010 Mar 30.

PMID:
20352465
33.

Neurological manifestations of Behçet's disease in Japan: a study of 54 patients.

Ideguchi H, Suda A, Takeno M, Kirino Y, Ihata A, Ueda A, Ohno S, Baba Y, Kuroiwa Y, Ishigatsubo Y.

J Neurol. 2010 Jun;257(6):1012-20. doi: 10.1007/s00415-010-5454-2. Epub 2010 Feb 3.

PMID:
20127350
34.

Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditions.

Miyazaki T, Kirino Y, Takeno M, Hama M, Ushihama A, Watanabe R, Takase K, Tachibana T, Matsumoto K, Tanaka M, Yamaji S, Ideguchi H, Tomita N, Fujita H, Ohno S, Ueda A, Ishigatsubo Y.

Int J Hematol. 2010 Mar;91(2):229-37. doi: 10.1007/s12185-010-0495-y. Epub 2010 Jan 22.

PMID:
20091384
35.

Successful switching to adalimumab in an infliximab-allergic patient with severe Behçet disease-related uveitis.

Takase K, Ohno S, Ideguchi H, Uchio E, Takeno M, Ishigatsubo Y.

Rheumatol Int. 2011 Feb;31(2):243-5. doi: 10.1007/s00296-009-1178-y. Epub 2009 Oct 9.

PMID:
19816689
36.

Hereditary spherocytosis in 3 children coexisting with UDP-glucuronyl transferase 1A1 deficiency.

Shiota M, Asada J, Nishida H, Kumakura A, Yoshioka T, Hata A, Watanabe K, Maruo Y, Kato J, Ideguchi H, Nakanishi H, Sugihara T, Hata D.

J Pediatr Hematol Oncol. 2009 Feb;31(2):121-3. doi: 10.1097/MPH.0b013e318190d9cf.

PMID:
19194197
37.

Mycobacterium tuberculosis-specific immunospot assay of pleural exudate mononuclear cells is useful for the exclusion of tuberculous pleuritis in patients with lupus pleuritis.

Takase K, Ohno S, Ideguchi H, Murakami S, Takeno M, Ishigatsubo Y.

Lupus. 2009 Feb;18(2):175-7. doi: 10.1177/0961203308094998.

PMID:
19151122
38.

A case of Poncet's disease (tuberculous rheumatism).

Ideguchi H, Ohno S, Takase K, Tsukahara T, Kaneko T, Ishigatsubo Y.

Rheumatol Int. 2009 Jul;29(9):1097-9. doi: 10.1007/s00296-008-0795-1. Epub 2008 Dec 3.

PMID:
19050894
39.

[Case of enzyme-linked immunoglobulin with persistent elevation of lactate dehydrogenase activity in serum by administration of an anti-psychotic drug].

Okamoto I, Ohkubo K, Kawashima H, Ideguchi H, Ono J.

Rinsho Byori. 2008 Aug;56(8):671-7. Japanese.

PMID:
18800622
40.

Thromboembolic complications in splenectomized patients with dominantly inherited beta-thalassemia.

Ohga S, Ideguchi H, Kato J, Ishimura M, Takada H, Harada N, Kawanaka H, Hattori Y, Kang D, Hamasaki N, Hara T.

Acta Haematol. 2008;120(1):31-5. doi: 10.1159/000151601. Epub 2008 Aug 27. No abstract available.

PMID:
18728358
41.

The efficacy and safety of bucillamine as a second-line DMARD in the treatment of rheumatoid arthritis: a retrospective cohort study.

Suda A, Nagaoka S, Ohono S, Ideguchi H, Soga T, Ishigatsubo Y.

Mod Rheumatol. 2008;18(6):609-14. doi: 10.1007/s10165-008-0103-7. Epub 2008 Aug 6.

PMID:
18682889
42.

Outcomes after switching from one bisphosphonate to another in 146 patients at a single university hospital.

Ideguchi H, Ohno S, Takase K, Ueda A, Ishigatsubo Y.

Osteoporos Int. 2008 Dec;19(12):1777-83. doi: 10.1007/s00198-008-0618-y. Epub 2008 May 6.

PMID:
18458987
43.

[Clinical trial and evaluation of a direct report system of panic values at Fukuoka University Hospital].

Uike Y, Ohkubo K, Matsuzaki T, Yamashita T, Harada S, Futata Y, Kawashima H, Ideguchi H, Ono J.

Rinsho Byori. 2007 Dec;55(12):1067-74. Japanese.

PMID:
18283858
44.

Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behçet's disease.

Kirino Y, Takeno M, Watanabe R, Murakami S, Kobayashi M, Ideguchi H, Ihata A, Ohno S, Ueda A, Mizuki N, Ishigatsubo Y.

Arthritis Res Ther. 2008;10(1):R16. doi: 10.1186/ar2367. Epub 2008 Jan 31.

45.

Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab.

Ideguchi H, Ohno S, Takase K, Hattori H, Kirino Y, Takeno M, Ishigatsubo Y.

Rheumatology (Oxford). 2007 Oct;46(10):1621-2. Epub 2007 Aug 27. No abstract available.

PMID:
17726035
46.

Severe hyperbilirubinemia in a 10-year-old girl with a combined disorder of hereditary spherocytosis and Gilbert syndrome.

Sugita K, Maruo Y, Kurosawa H, Tsuchioka A, Fujiwara T, Mori A, Ideguchi H, Eguchi M.

Pediatr Int. 2007 Aug;49(4):540-2. No abstract available.

PMID:
17587286
47.

Persistence with bisphosphonate therapy including treatment courses with multiple sequential bisphosphonates in the real world.

Ideguchi H, Ohno S, Hattori H, Ishigatsubo Y.

Osteoporos Int. 2007 Oct;18(10):1421-7. Epub 2007 Jun 19.

PMID:
17577595
48.
49.

Catastrophic antiphospholipid syndrome associated with malignancies (case report and review of the literature).

Ideguchi H, Ohno S, Ueda A, Ishigatsubo Y.

Lupus. 2007;16(1):59-64. Review.

PMID:
17283588
50.

Tumor necrosis factor alpha acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytes.

Kirino Y, Takeno M, Murakami S, Kobayashi M, Kobayashi H, Miura K, Ideguchi H, Ohno S, Ueda A, Ishigatsubo Y.

Arthritis Rheum. 2007 Feb;56(2):464-75.

Supplemental Content

Loading ...
Support Center